Literature DB >> 9311794

Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins.

S Niewiesk1, I Eisenhuth, A Fooks, J C Clegg, J J Schnorr, S Schneider-Schaulies, V ter Meulen.   

Abstract

Immune suppression during measles accounts for most of the morbidity and mortality associated with the virus infection. Experimental study of this phenomenon has been hampered by the lack of a suitable animal model. We have used the cotton rat to demonstrate that mitogen-induced proliferation of spleen cells from measles virus-infected animals is impaired. Proliferation inhibition is seen in all lymphocyte subsets and is not dependent on viral replication. Cells which express the viral glycoproteins (hemagglutinin and fusion protein) transiently by transfection induce proliferation inhibition after intraperitoneal inoculation, whereas application of a recombinant measles virus in which measles virus glycoproteins are replaced with the vesicular stomatitis virus G protein does not have an antiproliferative effect. Therefore, in vivo expression of measles virus glycoproteins is sufficient and necessary to induce inhibition of lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311794      PMCID: PMC192061          DOI: 10.1128/JVI.71.10.7214-7219.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys.

Authors:  M B McChesney; R S Fujinami; N W Lerche; P A Marx; M B Oldstone
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

2.  Measles virus-induced suppression of lymphocyte proliferation.

Authors:  M Sanchez-Lanier; P Guerin; L C McLaren; A D Bankhurst
Journal:  Cell Immunol       Date:  1988-10-15       Impact factor: 4.868

3.  The effect of measles virus infection on T and B lymphocytes in the mouse. I. Suppression of helper cell activity.

Authors:  H F McFarland
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

4.  Ileocolitis associated with measles (rubeola).

Authors:  G R Monif; C I Hood
Journal:  Am J Dis Child       Date:  1970-09

5.  Pathology of measles in rhesus monkeys.

Authors:  W C Hall; R M Kovatch; P H Herman; J G Fox
Journal:  Vet Pathol       Date:  1971       Impact factor: 2.221

6.  Age dependence of viral expression: comparative pathogenesis of two rodent-adapted strains of measles virus in mice.

Authors:  D E Griffin; J Mullinix; O Narayan; R T Johnson
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

7.  Fatal measles infection in marmosets pathogenesis and prophylaxis.

Authors:  P Albrecht; D Lorenz; M J Klutch; J H Vickers; F A Ennis
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

8.  T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella.

Authors:  P Arneborn; G Biberfeld
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle.

Authors:  M B McChesney; J H Kehrl; A Valsamakis; A S Fauci; M B Oldstone
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

10.  Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production.

Authors:  R L Hirsch; F Mokhtarian; D E Griffin; B R Brooks; J Hess; R T Johnson
Journal:  Clin Immunol Immunopathol       Date:  1981-12
View more
  32 in total

1.  Inhibition of in vitro leukocyte proliferation by morbilliviruses.

Authors:  J Heaney; T Barrett; S L Cosby
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals.

Authors:  Sallie R Permar; Diane E Griffin; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2006-04

Review 3.  Viral modulation of T-cell receptor signaling.

Authors:  Keith R Jerome
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

4.  Modeling Human Respiratory Viral Infections in the Cotton Rat (Sigmodon hispidus).

Authors:  Jorge Cg Blanco; Marina S Boukhvalova; Daniel R Perez; Stefanie N Vogel; Adriana Kajon
Journal:  J Antivir Antiretrovir       Date:  2014-03-03

5.  Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro.

Authors:  A Weidmann; A Maisner; W Garten; M Seufert; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.

Authors:  B Schlereth; J K Rose; L Buonocore; V ter Meulen; S Niewiesk
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus).

Authors:  Joanna Pfeuffer; Karen Püschel; Volker ter Meulen; Jürgen Schneider-Schaulies; Stefan Niewiesk
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice.

Authors:  B Mrkic; B Odermatt; M A Klein; M A Billeter; J Pavlovic; R Cattaneo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

9.  Measles virus-induced immunosuppression in vitro is independent of complex glycosylation of viral glycoproteins and of hemifusion.

Authors:  A Weidmann; C Fischer; S Ohgimoto; C Rüth; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

10.  Role of AKT kinase in measles virus replication.

Authors:  Mary Carsillo; Dhohyung Kim; Stefan Niewiesk
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.